GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
103 hedge funds and large institutions have $287M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more funds holding
Funds holding: 97 → 103 (+6)
Holders
103
Holding in Top 10
–
Calls
$1.42M
Puts
$676K
Top Buyers
| 1 | +$18.4M | |
| 2 | +$11M | |
| 3 | +$7.83M | |
| 4 |
Millennium Management
New York
|
+$5.55M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.32M |
Top Sellers
| 1 | -$19M | |
| 2 | -$5.54M | |
| 3 | -$4.52M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.79M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.88M |